These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Plasma, subcutaneous tissue and bone concentrations of ceftiofur sodium after regional limb perfusion in horses.
    Author: Cox KS, Nelson BB, Wittenburg L, Gold JR.
    Journal: Equine Vet J; 2017 May; 49(3):341-344. PubMed ID: 27458113.
    Abstract:
    REASONS FOR PERFORMING STUDY: Regional limb perfusion (RLP) is an effective treatment option for injuries and infections of the distal limb in horses. Using ceftiofur sodium in RLP has been studied due to its superior spectrum of Gram-positive organisms compared to aminoglycosides, but it is not known if this antimicrobial drug adequately penetrates subcutaneous tissue and bone. OBJECTIVE: To determine the concentration of ceftiofur in plasma, subcutaneous tissue and bone in horses after RLP. STUDY DESIGN: Experimental prospective study. METHODS: Six healthy horses were used in this study. Under standing sedation, an Esmarch tourniquet was applied to both proximal metacarpi and RLP was performed in each forelimb by injecting either ceftiofur sodium (experimental limb) or saline (control limb) i.v. in the lateral palmar digital vein. The experimental limb was injected with 2 g ceftiofur diluted to 60 mL with sterile saline. The control limb was injected with 60 mL of sterile saline. The tourniquet was left in place for 30 min post injection. Plasma, subcutaneous tissue and cortical bone samples were collected immediately after tourniquet removal (0.5 h), 12 and 24 h post injection. Ceftiofur concentrations and its active metabolite desfuroylceftiofur were analysed using high performance liquid chromatography-tandem mass spectrometry and the results were compared between control and experimental limbs using a Wilcoxon signed rank test. RESULTS: The median plasma concentrations were greater than the minimum inhibitory concentration (MIC) for common pathogens (1 μg/mL) at 0 and 12 h post RLP. The median subcutaneous tissue concentrations were greater than MIC (1 μg/g) at all 3 time points in the experimental limb. The median bone concentration was above MIC (1 μg/g) at time 0 in the experimental limb but was below MIC at 12 and 24 h in the experimental limb. CONCLUSIONS: Ceftiofur administration via RLP maintained plasma concentrations above MIC for 12 h. Subcutaneous tissue concentrations above MIC were maintained for 24 h. Bone concentrations were only above MIC immediately after tourniquet removal. Further research is needed to evaluate ceftiofur administration via RLP and its implications in disease states.
    [Abstract] [Full Text] [Related] [New Search]